ResearcherID - CLICK HERE Scientific Journal Impact Factor (SJIF-2020) - CLICK HERE




Dr. Muhammad Zubair,Dr.Salman Khan,Dr.Taj Mohammad Khan, Dr. Nisar Khan, Dr. Muhammad Imran Ullah, Altaf Ali Mangi


Diabetes Mellitus is a chronic health disorder that occurs when the pancreas does not produce sufficient amount of insulin, or when the body cannot effectively use the insulin it produces. This eventually leads to the raised concentration of glucose in the blood known as hyperglycemia. The present study was conducted to determine the frequency of dyslipidaemia in patients with type 2 diabetes mellitus. The study was carried out in the Department of Medicine of Ayub Teaching Hospital Abbottabad from April 2016 to October 2016. Methods: Patients were confirmed as diabetics by taking the history carefully of type-II diabetes for the last four years at least and were on oral anti diabetics or insulin but not taking the lipid lowering agents. Height and weight of all the patients were measured and BMI for every patient was calculated. Blood was taken in the fasting state for lipid profile, fasting blood glucose and glycosylated haemoglobin determination. Results: Out of total 196 In frequency distribution with HDL cholesterol group, there were 20(10.2%) male dyslipidemics patients found and 20(10.2%) female dyslipidemics patients, LDL cholesterol group, there were 64(32.7%) male dyslipidemics patients found and 52(26.5%) female dyslipidemics patients, triglycerides group, there were 52(26.5%) male dyslipidemics patients found and 28(14.3%) female dyslipidemics patients and total cholesterol group, there were 56(28.6%) male dyslipidemics patients found and 36(18.4%) female dyslipidemics patients. Conclusion: Present study showed the same as in many previous studies concluded that common lipid abnormalities during diabetes induced dyslipidemia. Aggressive lifestyle changes, such as weight reduction and physical exercise should be initiated first followed by medication with lipid lowering drugs Keywords: Dyslipidaemia, Glycosylated haemoglobin, Type 2 Diabetes mellitus.


  • Follows us on
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.